• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过足迹法估算宫颈癌缺失的流行病学数据:印度的一项案例研究。

Approximating missing epidemiological data for cervical cancer through Footprinting: A case study in India.

机构信息

Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.

出版信息

Elife. 2023 May 25;12:e81752. doi: 10.7554/eLife.81752.

DOI:10.7554/eLife.81752
PMID:37227260
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10212556/
Abstract

Local cervical cancer epidemiological data essential to project the context-specific impact of cervical cancer preventive measures are often missing. We developed a framework, hereafter named Footprinting, to approximate missing data on sexual behaviour, human papillomavirus (HPV) prevalence, or cervical cancer incidence, and applied it to an Indian case study. With our framework, we (1) identified clusters of Indian states with similar cervical cancer incidence patterns, (2) classified states without incidence data to the identified clusters based on similarity in sexual behaviour, (3) approximated missing cervical cancer incidence and HPV prevalence data based on available data within each cluster. Two main patterns of cervical cancer incidence, characterized by high and low incidence, were identified. Based on the patterns in the sexual behaviour data, all Indian states with missing data on cervical cancer incidence were classified to the low-incidence cluster. Finally, missing data on cervical cancer incidence and HPV prevalence were approximated based on the mean of the available data within each cluster. With the Footprinting framework, we approximated missing cervical cancer epidemiological data and made context-specific impact projections for cervical cancer preventive measures, to assist public health decisions on cervical cancer prevention in India and other countries.

摘要

本地宫颈癌流行病学数据对于预测宫颈癌预防措施的具体影响至关重要,但往往缺失。我们开发了一种名为“足迹”(Footprinting)的框架,用于近似估算性行为、人乳头瘤病毒(HPV)流行率或宫颈癌发病率等缺失数据,并将其应用于印度的案例研究。通过我们的框架,我们:(1) 确定了具有相似宫颈癌发病模式的印度邦聚类;(2) 根据性行为的相似性,将无发病数据的邦分类到已识别的聚类中;(3) 根据每个聚类内的现有数据,近似估算缺失的宫颈癌发病率和 HPV 流行率数据。确定了两种主要的宫颈癌发病率模式,其特征是发病率高和低。根据性行为数据中的模式,所有宫颈癌发病率缺失的印度邦都被归类为低发病率聚类。最后,根据每个聚类内可用数据的平均值,估算了宫颈癌发病率和 HPV 流行率的缺失数据。通过足迹框架,我们近似估算了缺失的宫颈癌流行病学数据,并对宫颈癌预防措施的具体影响进行了预测,以协助印度和其他国家在宫颈癌预防方面的公共卫生决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/10212556/d703769f1786/elife-81752-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/10212556/c5110cc2d2ff/elife-81752-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/10212556/6ee8811168e7/elife-81752-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/10212556/d3dd2acb121b/elife-81752-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/10212556/891163d52c92/elife-81752-fig2-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/10212556/e40965233df2/elife-81752-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/10212556/d703769f1786/elife-81752-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/10212556/c5110cc2d2ff/elife-81752-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/10212556/6ee8811168e7/elife-81752-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/10212556/d3dd2acb121b/elife-81752-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/10212556/891163d52c92/elife-81752-fig2-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/10212556/e40965233df2/elife-81752-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d001/10212556/d703769f1786/elife-81752-fig3-figsupp1.jpg

相似文献

1
Approximating missing epidemiological data for cervical cancer through Footprinting: A case study in India.通过足迹法估算宫颈癌缺失的流行病学数据:印度的一项案例研究。
Elife. 2023 May 25;12:e81752. doi: 10.7554/eLife.81752.
2
Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling study.基于证据的印度单次人乳头瘤病毒疫苗接种影响预测:建模研究。
Lancet Oncol. 2022 Nov;23(11):1419-1429. doi: 10.1016/S1470-2045(22)00543-5. Epub 2022 Sep 26.
3
Prevalence and determinants of high-risk human papillomavirus infection in middle-aged Indian women.中年印度女性高危型人乳头瘤病毒感染的流行状况及其决定因素。
Sex Transm Dis. 2011 Oct;38(10):902-6. doi: 10.1097/OLQ.0b013e318223be5f.
4
Global burden of human papillomavirus and related diseases.人乳头瘤病毒及相关疾病全球负担。
Vaccine. 2012 Nov 20;30 Suppl 5:F12-23. doi: 10.1016/j.vaccine.2012.07.055.
5
Social differences in sexual behaviour and cervical cancer.性行为与宫颈癌方面的社会差异。
IARC Sci Publ. 1997(138):309-17.
6
Analysis of time trends of prevalence of high-risk HPV infections, high grade cervical precancer and cervical cancer disease in women from Eastern India over 20 years - Pooled analysis from three studies.印度东部女性高危型人乳头瘤病毒感染、高级别宫颈上皮内瘤变和宫颈癌疾病患病率20年时间趋势分析——三项研究的汇总分析
Cancer Epidemiol. 2025 Apr;95:102776. doi: 10.1016/j.canep.2025.102776. Epub 2025 Feb 18.
7
Cervical cancer and human papillomavirus: epidemiological evidence and perspectives for prevention.宫颈癌与人乳头瘤病毒:流行病学证据及预防前景
Salud Publica Mex. 1997 Jul-Aug;39(4):274-82. doi: 10.1590/s0036-36341997000400005.
8
Do cervical cancer data justify HPV vaccination in India? Epidemiological data sources and comprehensiveness.宫颈癌数据是否证明 HPV 疫苗接种在印度合理?流行病学数据来源和全面性。
J R Soc Med. 2012 Jun;105(6):250-62. doi: 10.1258/jrsm.2012.110343.
9
Prevalence of human papilloma virus among cervical cancer patients in India: A systematic review and meta-analysis.印度宫颈癌患者人乳头瘤病毒感染率的系统评价和荟萃分析。
Medicine (Baltimore). 2024 Aug 2;103(31):e38827. doi: 10.1097/MD.0000000000038827.
10
Declining Prevalence of Human Papillomavirus Co-Infections Among Young Japanese Women With Cervical Cancer and Its Precursors.日本年轻宫颈癌患者及其癌前病变患者中人类乳头瘤病毒合并感染率的下降
J Med Virol. 2024 Dec;96(12):e70096. doi: 10.1002/jmv.70096.

引用本文的文献

1
Identifying Data-Driven Clinical Subgroups for Cervical Cancer Prevention With Machine Learning: Population-Based, External, and Diagnostic Validation Study.利用机器学习识别宫颈癌预防中数据驱动的临床亚组:基于人群的外部诊断验证研究
JMIR Public Health Surveill. 2025 Mar 19;11:e67840. doi: 10.2196/67840.
2
Health and economic effects of introducing single-dose or two-dose human papillomavirus vaccination in India.在印度引入单剂或两剂人乳头瘤病毒疫苗接种的健康和经济影响。
BMJ Glob Health. 2023 Nov;8(11). doi: 10.1136/bmjgh-2023-012580.
3
Building resilient cervical cancer prevention through gender-neutral HPV vaccination.

本文引用的文献

1
Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling study.基于证据的印度单次人乳头瘤病毒疫苗接种影响预测:建模研究。
Lancet Oncol. 2022 Nov;23(11):1419-1429. doi: 10.1016/S1470-2045(22)00543-5. Epub 2022 Sep 26.
2
The IARC Perspective on Cervical Cancer Screening.国际癌症研究机构对宫颈癌筛查的观点。
N Engl J Med. 2021 Nov 11;385(20):1908-1918. doi: 10.1056/NEJMsr2030640.
3
Predicting Cohort-Specific Cervical Cancer Incidence From Population-Based Surveys of Human Papilloma Virus Prevalence: A Worldwide Study.
通过对 HPV 疫苗接种进行性别中立化来建立有弹性的宫颈癌预防措施。
Elife. 2023 Jul 24;12:e85735. doi: 10.7554/eLife.85735.
基于 HPV 流行率的人群普查预测宫颈癌发病的队列特异性:一项世界性研究。
Am J Epidemiol. 2022 Feb 19;191(3):402-412. doi: 10.1093/aje/kwab254.
4
Global estimates of expected and preventable cervical cancers among girls born between 2005 and 2014: a birth cohort analysis.2005年至2014年间出生女孩中预期和可预防宫颈癌的全球估计:一项出生队列分析。
Lancet Public Health. 2021 Jul;6(7):e510-e521. doi: 10.1016/S2468-2667(21)00046-3. Epub 2021 Apr 15.
5
Trajectory clustering using mixed classification models.基于混合分类模型的轨迹聚类。
Stat Med. 2021 Jul 10;40(15):3425-3439. doi: 10.1002/sim.8975. Epub 2021 Apr 7.
6
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
7
HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019.HPV 疫苗接种在全球范围内的推广情况以及世卫组织和儿基会对 2010-2019 年各国 HPV 免疫接种覆盖率的估计。
Prev Med. 2021 Mar;144:106399. doi: 10.1016/j.ypmed.2020.106399. Epub 2020 Dec 31.
8
The cost-effectiveness profile of sex-neutral HPV immunisation in European tender-based settings: a model-based assessment.基于模型评估的欧洲招标环境中性 HPV 免疫接种的成本效益概况。
Lancet Public Health. 2020 Nov;5(11):e592-e603. doi: 10.1016/S2468-2667(20)30209-7.
9
HPV Vaccination and the Risk of Invasive Cervical Cancer.HPV 疫苗接种与浸润性宫颈癌风险。
N Engl J Med. 2020 Oct 1;383(14):1340-1348. doi: 10.1056/NEJMoa1917338.
10
Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.HPV 疫苗接种和宫颈筛查对宫颈癌消除的影响:78 个低收入和中低收入国家的比较建模分析。
Lancet. 2020 Feb 22;395(10224):575-590. doi: 10.1016/S0140-6736(20)30068-4. Epub 2020 Jan 30.